Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202753019 | Acetaminophen + propoxyphene napsylate 325mg/50mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215609018 | Acetaminophen + propoxyphene napsylate 325mg/50mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478793019 | Acetaminophen+propoxyphene napsylate 325mg/50mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2154785014 | Paracetamol + propoxyphene napsylate 325mg/50mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3469794017 | Product containing acetaminophen 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469795016 | Product containing paracetamol 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490489015 | Product containing paracetamol 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501704011 | Paracetamol 325 mg and propoxyphene napsylate 50 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501705012 | Acetaminophen 325 mg and propoxyphene napsylate 50 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3569350018 | Product containing only acetaminophen 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569351019 | Product containing only paracetamol 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569352014 | Product containing only paracetamol 325 mg and propoxyphene napsylate 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681585014 | Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681586010 | Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681587018 | Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 105048201000001111 | Paracetamol + propoxyphene napsylate 325mg/50mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing dextropropoxyphene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Opiate agonist (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol and propoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with opioid receptor agonist mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has active ingredient | Dextropropoxyphene napsylate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Has precise active ingredient | Dextropropoxyphene napsylate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing dextropropoxyphene and paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet | Is a | Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR